Avammune Therapeutics
About Avammune Therapeutics
Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and development, specifically targeting modulators of the innate immune system to treat cancer and autoimmune disorders.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | May 12, 2025 | $12.0M | M2Biome, Shastra VC, Kotak Alternate Asset Managers’ Life Sciences Fund I +2 more |
Founders
Arun B Papaiah
Founder and Chief Executive Officer
Srinivasan
Founder & CEO
Investors
Kotak Alternate Asset Managers’ Life Sciences Fund I
Venture Capital
Kotak Alternate Asset Managers’ Life Sciences Fund I
Venture Capital
Kotak Alternate Asset Managers’ Life Sciences Fund I
Venture Capital
M2Biome
Corporate
Shastra VC
Venture Capital
Recent Mentions
Healthtech startup Avammune Therapeutics has raised $12 Mn (INR 100 Cr) as a part of its Series A funding round co-led by Capital 2B, Shastra VC and Kotak Alternate Asset Managers’ Life Sciences Fund I. https://t.co/kpO9sYsfXH
Healthtech startup Avammune Therapeutics has raised $12 Mn (INR 100 Cr) as a part of its Series A funding round co-led by Capital 2B, Shastra VC and Kotak Alternate Asset Managers’ Life Sciences Fund I. The company plans to use the fresh capital to boost its IP portfolio and https://t.co/PzGlTzFtMG
#Update Bengaluru-based healthtech startup Avammune Therapeutics secured INR 100 crore ($12 million) in a Series A funding round led by Capital 2B, Shastra VC, and Kotak Alternate Asset Managers, with participation from others. Founded in 2020 by Arun B Papaiah, Srinivasan https://t.co/7UGfFz0yvs
Healthtech startup Avammune Therapeutics has raised $12 Mn (INR 100 Cr) as a part of its Series A funding round co-led by Capital 2B, Shastra VC and Kotak Alternate Asset Managers’ Life Sciences Fund I. https://t.co/yhmieMdxMh
Similar Startups
Vima Therapeutics
88% matchVima Therapeutics is a biotechnology startup focused on developing innovative therapies to address u...
LTZ Therapeutics
86% matchLTZ Therapeutics is an immunotherapy-focused global biotech startup dedicated to developing myeloid ...
Alpheus Medical
86% matchA private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...
CureGene Pharma
86% matchCureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...